Sophie Bushwick, senior editor for Popular Science, discusses the Trump administration's recent announcement to scale back the size of two national monuments in Utah, which are home to over 400 research sites employing 2,000 scientists.
The administration will scale back the size of Grand Staircase-Escalante and Bear's End. Scientists are suing to reverse the decision because of the disruption it will cause in paleontology and other scientific research endeavors.
We discuss Patagonia and R.E.I.'s opposition to the decision and whether a compromise can be made between the government and researchers.
Blame geography for the U.S. getting hit by stronger, costlier, more varied and frequent extreme weather than anywhere on the planet, several experts said. But that's only part of it.
Residents across a wide swath of the U.S. raced Sunday to assess the destruction from fierce storms that spawned possibly dozens of tornadoes from the South and the Midwest into the Northeast.
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
